Purified Lipoproteins
Purified native human apolipoproteins, recombinant human
apoplipoproteins, polyclonal and monoclonal antibodies to
apolipoproteins, purified native human lipoproteins, modified human
lipoproteins, lipoprotein probes, media supplements,

Intracel is a biopharmaceutical company that manufactures a
comprehensive range of products for cardiovascular research:
Human lipoproteins: VLDL, LDL, HDL, Lp(a)
Isolated by ultracentrifugation yielding pure, intact, native
particles
Custom Purification
Modified Human Lipoproteins: Acetylated LDL, Oxidized
LDL.
Lipoprotein modifications are made monthly in order to ensure
freshness
Lipoproteins from Intracel are manufactured according to a
monthly production schedule and have limited shelf life.
Please click here for
further details.
Lipoprotein Probes
Fluorescent labeled lipoproteins: LDL, HDL, Acetylated LDL,
Oxidized LDL
Biotinylated lipoproteins: LDL, HDL, VLDL
Human Apoplipoproteins: A-I, A-II, B-100, C-I,
C-II, C-III, E, H
Isolated by proprietary HPLC methods
Recombinant Human Apolipoproteins: Apo E-2, E-3,
E-4
Apo E-2: associated with hyperlipidemia
Apo E-3: considered the wild type
Apo E-4: associated with sporadic and late onset Alzheimer's
disease
Monoclonal Antibodies to Apolipoproteins
Monoclonal and polyclonal
Specific cognate antigen with no cross-reactivity with other
apolipoproteins or serum proteins
High affinity
Media Supplements
Endothelial Cell Growth Supplement
Human lipoprotein-deficient serum or plasma
Fetal bovine lipoprotein-deficient serum
Search here
| Cat. No |
Name |
Raised In |
Applications |
Species Reactivity |
| ABC1543 |
Low Density Lipoprotein |
|
PC |
human |
| RP-029 |
Human Lipoprotein VLDL |
|
|
|
| RP-030 |
Human Lipoprotein VLDL |
|
|
|
| RP-031 |
Human Lipoprotein LDL |
|
|
|
| RP-032 |
Human Lipoprotein LDL |
|
|
|
| RP-033 |
Human Lipoprotein LDL |
|
|
|
| RP-034 |
Human Lipoprotein LDL |
|
|
|
| RP-035 |
Human Lipoprotein HDL |
|
|
|
| RP-036 |
Human Lipoprotein HDL |
|
|
|
| RP-037 |
Human Lipoprotein HDL |
|
|
|
|
|
|
|
|